Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4A03

Crystal Structure of Mycobacterium tuberculosis DXR in complex with the antibiotic FR900098 and cofactor NADPH

4A03 の概要
エントリーDOI10.2210/pdb4a03/pdb
関連するPDBエントリー2C82 2JCV 2JCX 2JCY 2JCZ 2JD0 2JD1 2JD2 2Y1C 2Y1D 2Y1E 2Y1F 2Y1G
分子名称1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE, MANGANESE (II) ION, 3-[ethanoyl(hydroxy)amino]propylphosphonic acid, ... (6 entities in total)
機能のキーワードoxidoreductase, fr900098, mep pathway
由来する生物種MYCOBACTERIUM TUBERCULOSIS
タンパク質・核酸の鎖数2
化学式量合計85489.01
構造登録者
Bjorkelid, C.,Bergfors, T.,Jones, T.A. (登録日: 2011-09-07, 公開日: 2012-01-18, 最終更新日: 2023-12-20)
主引用文献Bjorkelid, C.,Bergfors, T.,Unge, T.,Mowbray, S.L.,Jones, T.A.
Structural Studies on Mycobacterium Tuberculosis Dxr in Complex with the Antibiotic Fr-900098.
Acta Crystallogr.,Sect.D, 68:134-, 2012
Cited by
PubMed Abstract: A number of pathogens, including the causative agents of tuberculosis and malaria, synthesize the essential isoprenoid precursor isopentenyl diphosphate via the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway rather than the classical mevalonate pathway that is found in humans. As part of a structure-based drug-discovery program against tuberculosis, DXR, the enzyme that carries out the second step in the MEP pathway, has been investigated. This enzyme is the target for the antibiotic fosmidomycin and its active acetyl derivative FR-900098. The structure of DXR from Mycobacterium tuberculosis in complex with FR-900098, manganese and the NADPH cofactor has been solved and refined. This is a new crystal form that diffracts to a higher resolution than any other DXR complex reported to date. Comparisons with other ternary complexes show that the conformation is that of the enzyme in an active state: the active-site flap is well defined and the cofactor-binding domain has a conformation that brings the NADPH into the active site in a manner suitable for catalysis. The substrate-binding site is highly conserved in a number of pathogens that use this pathway, so any new inhibitor that is designed for the M. tuberculosis enzyme is likely to exhibit broad-spectrum activity.
PubMed: 22281742
DOI: 10.1107/S0907444911052231
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.65 Å)
構造検証レポート
Validation report summary of 4a03
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon